Skip to main content
SpringerLink
Log in

Radiofrequency Ablation of Hepatocellular Carcinoma

  • Chapter
Book cover Radiofrequency Ablation for Cancer

Summary

The use of RF energy to treat unresectable liver tumors is unlikely to be curative for most patients; however, a subset of patients treated with RFA may achieve long-term disease-free survival. Longer follow-up of hepatic tumor patients treated with RFA is needed to determine long-term disease-free and overall survival rates. New metastatic tumors develop in many of these patients at an incidence rate comparable with those treated with surgical resection or cryoablation. Surgical resection remains the gold standard for treating primary liver tumors; however, few patients are candidates for hepatic resection because of tumor size, number, location, or the presence of cirrhosis too severe to permit liver resection. Cryoablation of unresectable tumors has been an option for several years, but complications associated with the freezing of tissue can be problematic. RFA of unresectable liver tumors provides a relatively safe, highly effective method to achieve local disease control in some liver cancer patients who are not candidates for liver resection. Ongoing research and refinements in RF techniques and equipment may permit effective treatment of larger liver tumors and of malignant tumors at other body sites. Combining RFA of liver tumors with regional and/or systemic adjuvant treatments is being studied in attempts to reduce the incidence of development of new metastases, and thus improve the overall survival rates of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Di Bisceglie A, Rustgi V, Hoofnagle J, et al. NIH conference on hepatocellular carcinoma. Ann Intern Med 1988; 108:390–401.

    PubMed  Google Scholar 

  2. Liver Cancer Study Group of Japan. Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211:277–284.

    Google Scholar 

  3. Nagorney DM, van Heerden JA, Ilstrup DM, et al. Primary hepatic malignancy: surgical management and determinants of survival. Surgery 1989; 106:740–748.

    PubMed  CAS  Google Scholar 

  4. McGahan JP, Browning PD, Brock JM, et al. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25:267–270.

    PubMed  CAS  Google Scholar 

  5. Lounsberry W, Goldschmidt V, Linke C. The early histologic changes following electrocoagulation. Gastrointest Endosc 1995; 41:68–70.

    Article  Google Scholar 

  6. LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions. Semin Intervent Radiol 1997; 14(3):313–324.

    Google Scholar 

  7. Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review. Ann NY Acad Sci 1980; 335:180–205.

    PubMed  CAS  Google Scholar 

  8. Hill RP, Hunt JW. Hyperthermia. In: Tannock IF, Hill RP, eds. The Basic Science of Oncology. New York: Pergamon Press, 1987: 337–357.

    Google Scholar 

  9. Haines DE, Watson DD, Halperin C. Characteristics of heat transfer and determination of temperature gradient and viability threshold during radiofrequency fulguration of isolated perfused canine right ventricle. Circulation 1987; 76:278–283.

    Google Scholar 

  10. Grundfest WS, Litvack FI, Doyle DL, et al. Laser-tissue interactions: considerations for cardiovascular applications. In: White RA, Grundfest WS, eds. Lasers in Cardiovascular Disease. Chicago: Year-book Medical Publishers, 1987: 32–43.

    Google Scholar 

  11. Bischof J, Christov K, Rubinsky B. A morphological study of cooling rate response in normal and noeplastic human liver tissue: cryo-surgical implications. Cryobiology 1993; 30:482–492.

    Article  PubMed  CAS  Google Scholar 

  12. Steeves RA. Hyperthermia in cancer therapy: Where are we today and where are we going? Bull N Y Acad Med 1992; 68:341–350.

    PubMed  CAS  Google Scholar 

  13. Siperstein AE, Rogers SJ, Hansen PD, et al. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery 1997; 122:1147–1155.

    Article  PubMed  CAS  Google Scholar 

  14. Goldburg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumors using percutaneous RF therapy. Am J Res 1998; 170:1023–1028.

    Google Scholar 

  15. Lencioni R, Goletti O, Armillotta N, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998; 8(7):1205–1211.

    Article  PubMed  CAS  Google Scholar 

  16. Nagata Y, Hiraoka M, Nishimura Y, et al. Clinical results of radiofrequency hyperthermia for malignant liver tumors. Int J Radiat Oncol Biol Phys 1997; 38(2):359–365.

    Article  PubMed  CAS  Google Scholar 

  17. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230(1):1–8.

    Article  PubMed  CAS  Google Scholar 

  18. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000; 7(8):593–600.

    PubMed  CAS  Google Scholar 

  19. McGahan JP, Brock JM, Tesluk H, et al. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Intervent Radiol 1992;3:291–297.

    Article  CAS  Google Scholar 

  20. Curley SA, Izzo F, Ellis L, et al. Radiofrequency ablation of malignant liver tumors in 304 patients. Proceedings ASCO 2000; 19:248a.

    Google Scholar 

  21. Curley SA, Davidson BS, Fleming RYD, et al. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver. Surg Endosc 1997; 11:729–733.

    Article  PubMed  CAS  Google Scholar 

  22. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 cirrhotic patients. Ann Surg 2000; 232:381–391.

    Article  PubMed  CAS  Google Scholar 

  23. Patterson J, Strang R. The role of blood flow in hyperthermia. Int J Radiat Oncol Biol Phys 1979; 5:235–242.

    PubMed  CAS  Google Scholar 

  24. Kolios MC, Sherar MD, Hunt JW. Large blood vessel cooling in heated tissues: a numerical study. Phys Med Biol 1995; 40:477–494.

    Article  PubMed  CAS  Google Scholar 

  25. Sturesson C, Liu DL, Stenram U, et al. Hepatic inflow occlusion increases the efficacy of interstitial laser-induced thermotherapy in rats. J Surg Res 1997; 71:67–72.

    Article  PubMed  CAS  Google Scholar 

  26. Quebbeman EJ, Wallace JR. Cryosurgery for hepatic metastases. In: Condon RE, ed. Current Techniques in General Surgery. New York: Mosby, 1997: 1–75.

    Google Scholar 

  27. Gagne DJ, Roh MS. Cryosurgery for hepatic malignancies. In: Curley SA, ed. Liver Cancer. New York: Springer-Verlag, 1998: 173–200.

    Google Scholar 

  28. McCarty TM, Kuhn JA. Cryotherapy for liver tumors. Oncology 1998; 12(7):979–987.

    PubMed  CAS  Google Scholar 

  29. Seifert JK, Morris DL. World survey on the complication of hepatic and prostate cryotherapy. World J Surg 1999; 23(2):109–113.

    Article  PubMed  CAS  Google Scholar 

  30. Pearson AS, Izzo F, Fleming RYD, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999; 178:592–599.

    Article  PubMed  CAS  Google Scholar 

  31. Ross WB, Horton M, Bertolino P, et al. Cryotherapy of liver tumours: a practical guide. HPB Surg 1995; 8:167–173.

    PubMed  CAS  Google Scholar 

  32. Morris DL, Ross WB. Australian experience of cryoablation of liver tumors. Surg Oncol Clin North Am 1996; 52:391–397.

    Google Scholar 

  33. Cuschieri A, Crosthwaite G, Shimi S, et al. Hepatic cryotherapy for liver tumors. Surg Endosc 1995; 9:483–489.

    Article  PubMed  CAS  Google Scholar 

  34. Cozzi PJ, Stewart GJ, Morris DL. Thrombocytopenia after cryotherapy for colorectal metastases: correlates with hepatocellular injury. World J Surg 1994; 18:774–776.

    Article  PubMed  CAS  Google Scholar 

  35. Shafir M, Shapiro R, Sung M. Cryoablation of unresectable malignant liver tumors. Am J Surg 1996; 171:27–31.

    Article  PubMed  CAS  Google Scholar 

  36. Sarantou T, Bilchik A, Ramming KP. Complications of hepatic cryosurgery. Semin Surg Oncol 1998; 14(2):156–162.

    Article  PubMed  CAS  Google Scholar 

  37. Riley DK, Babinchak TJ, Zemel R, et al. Infection complications of hepatic cryosurgery. Clin Infect Dis 1997; 24:1001–1003.

    PubMed  CAS  Google Scholar 

  38. Zhou XD, Tang ZY. Cryotherapy for primary liver cancer. Semin Surg Oncol 1998; 14:171–174.

    Article  PubMed  CAS  Google Scholar 

  39. Lin DY, Lin SM, Liaw YF. Non-surgical treatment of hepatocellular carcinoma. J Gastroenterol Hepatol 1997; 12:S319–S328.

    PubMed  CAS  Google Scholar 

  40. Livraghi T, Bolondi L, Lazzaroni S, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69:925–929.

    PubMed  CAS  Google Scholar 

  41. Fujimoto T. The experimental and clinical studies of percutaneous ethanol injection therapy (PEIT) under ultrasonography for small hepatocellular carcinoma. Acta Hepatol Jpn 1988; 29:52–56.

    Google Scholar 

  42. Hasegawa S, Yamaski N, Hiwaki T, et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999; 86:1682–1690.

    Article  PubMed  CAS  Google Scholar 

  43. Seki T, Wakabayashi M, Nakagawa T, et al. Percutaneous microwave coagulation therapy for solitary metastatic liver tumors from colorectal cancer: a pilot clinical study. Am J Gastroenterol 1999; 94:322–327.

    Article  PubMed  CAS  Google Scholar 

  44. Yamashita Y, Sakai T, Maekawa T, et al. Thoracoscopic transdiaphragmatic microwave coagulation therapy for a liver tumor. Surg Endosc 1998; 12:1254–1258.

    Article  PubMed  CAS  Google Scholar 

  45. Vogl TJ, Mack MG, Roggan A, et al. Internally cooled power laser for MR-guided interstitial laser-induced thermotherapy of liver lesions: initial clinical results. Radiology 1998; 209:381–385.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Steven A. Curley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco Izzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Curley, S.A., Izzo, F. (2004). Radiofrequency Ablation of Hepatocellular Carcinoma. In: Radiofrequency Ablation for Cancer. Springer, New York, NY. https://doi.org/10.1007/0-387-21598-0_6

Download citation

  • DOI: https://doi.org/10.1007/0-387-21598-0_6

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95564-3

  • Online ISBN: 978-0-387-21598-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation